Home > Cardiology > ACC 2022 > Interventional and Structural Cardiology > No FLAVOUR difference between FFR and IVUS for PCI guidance

No FLAVOUR difference between FFR and IVUS for PCI guidance

Presented By
Prof. Bon-Kwon Koo, Seoul National University College of Medicine, Korea
Conference
ACC 2022
Trial
FLAVOUR
Doi
https://doi.org/10.55788/175da134
Among patients with intermediate coronary stenosis, using fractional flow reserve (FFR) to guide percutaneous coronary intervention (PCI) and optimise stent implantation was non-inferior to using intravascular ultrasound (IVUS) guidance. The FLAVOUR trial (NCT02673424), presented by Prof. Bon-Kwon Koo (Seoul National University College of Medicine, Korea), was designed to test the non-inferiority of FFR-guided PCI versus IVUS-guided PCI in patients with intermediate coronary stenosis [1]. PCI was indicated in the FFR arm if FFR was ≤0.8 and considered optimised if post-PCI FFR was ≥0.88; for the IVUS arm, PCI was indicated if the minimal luminal area (MLA) was ≤3 mm2, or >3 to 4 mm2 with a plaque burden of >70% and considered optimised if post-PCI MLA ≥5.5 mm2 and plaque burden at stent edge ≤55%. The primary endpoint was a co...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on